Real-time enrollment status for this primary central nervous system lymphoma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07015242 |
| Recruiting Status | Recruiting |
| Condition | Primary Central Nervous System Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 65 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | September 30, 2026 (3 weeks ago) |
As of October 21, 2026: Clinical trial NCT07015242 is currently recruiting participants. This phase2 study for primary central nervous system lymphoma is actively seeking new participants at 14 locations across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07015242 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07015242 was last updated 3 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.